U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951503) titled 'A Phase III, Randomized, Controlled and Multi-center Study of AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer' on April 23.
Brief Summary: This trial is a Phase III study. The purpose of this study is to evaluate the efficacy and safety of AK112 and chemotherapy versus bevacizumab and chemotherapy for the first-line treatment of metastatic colorectal cancer.
Study Start Date: May 09
Study Type: INTERVENTIONAL
Condition:
Colorectal Adenocarcinoma
Intervention:
DRUG: AK112
iv, q2w
DRUG: Oxaliplatin
iv, q2w
DRUG: Irinotecan
iv, q2w
DRUG: Leucovorin and 5-FU
iv, q2w
DRUG: Bevacizumab
iv, q2w
Recruitment S...